Esperion Therapeutics Balance Sheet - Annual (NASDAQ:ESPR)

Add to My Stocks
$38.27 $0.67 (1.72%) ESPR stock closing price Mar 27, 2017 (Closing)

A thorough fundamental analysis involves using data from Esperion Therapeutics balance sheet, apart from other financial statements, to value the business. Financial strength can be guaged by performing Esperion Therapeutics stock analysis and by analyzing the balance sheet. A company releases its balance sheet every quarter along with its quarterly results. The Esperion Therapeutics balance sheet for 2016 shows cash on hand of $38.16M. The cash has decreased by $39.17M. View latest and last 10 year balance sheet data to check Esperion Therapeutics financial performance..

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2016 2015 2014 2013 2012 2011
Cash38.16M77.33M85.03M56.53M6.51M1.57M
Marketable Securities173.41M134.92M20.8M3.52M--
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets1.99M2.13M0.92M0.55M0.62M0.29M
Esperion Therapeutics Total Current Assets
213.57M214.39M106.76M60.61M7.13M1.86M
Property Plant & Equipment1.28M1.16M1.18M0.76M--
Accumulated Depreciation0.6M0.35M0.4M0.68M--
Esperion Therapeutics Net Property Plant & Equipment
0.67M0.8M0.78M0.08M0.12M0.25M
Investment & Advances30.9M80.31M35.74M17.53M--
Other Non-Current Assets------
Deferred Charges------
Intangibles0.05M0.05M0.05M0.05M0.05M0.05M
Deposits & Other Assets-----0.01M
Esperion Therapeutics Total Assets
245.21M295.57M143.34M78.29M7.31M2.17M
Notes Payable------
Accounts Payable4.59M0.7M2.04M2.23M0.47M0.69M
Current Portion Long-Term Debt1.7M1.6M0.63M-15.24M-
Current Portion Capital Leases------
Accrued Expenses9.28M3.31M2.81M1.97M1.19M0.2M
Income Taxes Payable------
Other Current Liabilities----0.26M0.44M
Esperion Therapeutics Total Current Liabilities
15.58M5.62M5.49M4.2M17.17M1.33M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt1.02M2.68M4.29M-7.52M6.89M
Non-Current Capital Leases------
Other Long-Term Liabilities------
Esperion Therapeutics Total Liabilities
16.61M8.31M9.79M4.2M24.7M8.23M
Minority Interest------
Preferred Stock----23.97M23.97M
Common Stock Net0.02M0.02M0.02M0.01M--
Capital Surplus457.95M441.94M238.03M142.14M0.6M0.2M
Retained Earnings-229.2M-154.22M-104.43M-68.06M-41.97M-30.23M
Treasury Stock------
Other Liabilities-0.17M-0.48M-0.05M---
Esperion Therapeutics Shareholders Equity
228.6M287.25M133.55M74.09M-17.38M-30.03M
Esperion Therapeutics Total Liabilities & Shareholders Equity
245.21M295.57M143.34M78.29M7.31M2.17M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Balance sheet for another ticker

Looking at Esperion Therapeutics historical stock prices and the current Esperion Therapeutics stock price can tell you how the stock price has moved, whereas the Esperion Therapeutics PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:
  • Assets: Anything that the Esperion Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Esperion Therapeutics had total assets of $245.21M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ESPR stock had total liabilities of $16.61M for year 2016.
.